Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21

Trial Status

Other3

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer
FractionationLung CancerRadiotherapy+1 more
PrincipalinvestigatorStart date: 2018-01-07
NCT05802654Not ApplicableNot Yet Recruiting
Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer
Early Lung CancerStereotactic Body Radiotherapy
Studychair
NCT05915481Phase 1/2Unknown
Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors
Advanced Solid TumorEfficacyImmune Checkpoint Inhibitor+2 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT05802641PrincipalInvestigator

Stereotactic Radiotherapy With Different Fractionation Modes for the Early Lung Cancer

FractionationLung CancerRadiotherapy+1 more
Unknown
NCT05802654Not ApplicableStudyChair

Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer

Early Lung CancerStereotactic Body Radiotherapy
Not Yet Recruiting
NCT05915481Phase 1/2PrincipalInvestigator

Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors

Advanced Solid TumorEfficacyImmune Checkpoint Inhibitor+2 more
Unknown

All 3 trials loaded